ANALISIS COST OF ILLNESS DAN LAMA RAWAT INAP PADA PASIEN STEVENS JOHNSON SYNDROME DAN TOXIC EPIDERMAL NECROLYSIS DARI PERSPEKTIF RUMAH SAKIT DI RSUP DR. SARDJITO YOGYAKARTA
DOI:
https://doi.org/10.12928/mf.v16i1.14642Keywords:
Stevens-Johnson Syndrom, Toxic Epidermal Necrolysis, cost of illness, lama rawat inapAbstract
Stevens-Johnson Syndrom (SJS) dan Toxic Epidermal Necrolysis (TEN) merupakan suatu reaksi hipesensitivitas akut ditandai dengan nekrosis kutaneus dan masuk 10 besar efek samping terbanyak yang dilaporkan di Indonesia sebesar 3%. Banyaknya terapi dan lama perawatan diRumah sakit berdampak pada meningkatnya morbiditas, mortalitas dan biaya kesehatan. Tujuan dari penelitian inia adalah mengetahui cost of illness dan perbandingan lama rawat inap pada pasien SJS dan TEN akibat penggunaan obat dari perspektif rumah sakit. Design penelitian ini
adalah cross sectional study dengan pengambilan data retrospektif. Data yang diambil adalah pasien yang terdiagnosa SJS dan TEN akibat penggunaan obat dan menjalani rawat inap di RSUP Dr. Sardjito Yogyakarta selama periode tahun 2014-2018 sesuai kreteria inklusi dan
eksklusi. Sebanyak 48 pasien dilibatkan dengan diagnosa SJS sebanyak 41 pasien dan TEN sebanyak 7 pasien. Rata-rata total biaya pasien SJS sebesar Rp. 16.546.233,0224±16.091.819,01889, sedangkan untuk pasien TEN sebesar 14.356.586,2086 ± 6.645.740,75924. Rata-rata lama rawat inap pasien SJS (12,66±5,77 hari) dan TEN (13,29±3,03 hari). Tidak terdapat perbedaan signifikan rata-rata total biaya dan lama rawat inap antar pasien SJS dan TEN dimana nilai p > 0,05. SJS dan TEN tidak terdapat perbedaaan signifikan tetapi dapat menjadi beban biaya cukup tinggi dan peningkatan durasi lama rawat inap bagi pasien.
References
Abdulah, R., Suwandiman, T. F., Handayani, N., Destiani, D. P., Suwantika, A. A., Barliana, M. I., & Lestari, K., 2017, Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS-TEN overlap and potential drug–drug interactions during treatment: A retrospective analysis at an indonesian referral hospital, Therapeutics and Clinical Risk Management, 13 : 919–925. https://doi.org/10.2147/TCRM.S142226
Badan POM RI, 2016, Profil Laporan Efek Samping Obat, Badan POM RI Bulletin Berita MESO, vol. 34, no. 1 : 1-7.
Dahlan, S.M., 2015, Statistik untuk Kedokteran dan Kesehatan: Deskriptif, Bivariat, dan Multivariat Dilengkapi Aplikasi dengan Menggunakan SPSS, Edisi 6, Salemba Medika : Jakarta : 92-105.
Dilokthornsakul, P., Sawangjit, R., Inprasong, C., Chunhasewee, S., Rattanapan, P., Thoopputra, T., & Chaiyakunapruk, N., 2016, Healthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in Thailand. Journal of postgraduate medicine, 62(2) : 109–114. doi:10.4103/0022-3859.180571.
Murti, T., 2013. Farmakoekonomi prinsip dan metodologi, Bursa Ilmu : Yogyakarta : 27-37.
Saka B, Kombate K, Mouhari-Toure A, Akakpo S, Tchangaï-Walla K, Pitché P., 2010, Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases. Med Trop (Mars) 70: 255–258.
Tejas, K.P., Manish, J.B., Dineshchandra, S., dan CHandrabhanu, T., 2013, A systematic review of the drug-induced Stevens Johnson syndrome and toxic epidermal necrolysis in Indian population, Indian Journal of Dermatology, Venereology, and Leprology, 79(3) : 389-398.
Tirado, V.V., Montserrat, A.S., Adriana, C.Q., Angela, R.S., Leire, S.A., Amparo, L.B., Javier, P.L., Moncef, B.G., 2018, Life threatening dermatoses: Stevens Johnson Syndrome and Toxic EpidermalNecrolysis. Impact on the Spanish publichealth system (2010-2015), PLOS ONE.
Trask, L. S., 2011, Chapter 1. Pharmacoeconomics: Principles, Methods, and Applications. In J. T. DiPiro, R. L. Talbert, G. C. Yee, G. R. Matzke, B. G. Wells, & L. M. Posey (Eds.), Pharmacotherapy: A Pathophysiologic Approach, 8e. New York, NY: The McGraw-Hill Companies. Retrieved from http://accesspharmacy.mhmedical.com/content.aspx?aid=7965001.
Wong, A., Malvestiti, A. A., & Hafner, M. de F. S., 2016, Stevens-Johnson syndrome and toxic epidermal necrolysis: a review. Revista Da Associação Médica Brasileira, 62(5) : 468–473. https://doi.org/10.1590/1806-9282.62.05.468.
Yang, M., Kim, J., Kang, M., Lee, S., Jung, J., Cho, S., Kang, H., 2019, Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea, 195–201.
Downloads
Published
Issue
Section
License
Authors who publish with Media Farmasi agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution 4.0 International License
